F. Kano

发表

Inhibitory effects of 9-(4-thio-beta-D-ribo-pentofuranosyl)guanine on tumor growth and angiogenesis.

Kohei Yamada, Y. Yoshimura, S. Miura, 2004, Biological & pharmaceutical bulletin.

Deglycosylation of antiherpesviral 5-substituted arabinosyluracil derivatives by rat liver extract and enterobacteria cells.

T. Yamaguchi, H. Machida, Y. Watanabe, 1995, Biochemical pharmacology.

SYNTHESIS AND BIOLOGICAL EVALUATION OF 1'-C-CYANO-PYRIMIDINE NUCLEOSIDES

T. Miyasaka, Y. Itoh, K. Haraguchi, 1996 .

Novel uracil derivatives: newly synthesized centrally acting agents.

M. Imaizumi, S. Sakata, F. Kano, 1992, Chemical & pharmaceutical bulletin.

Comparison of the Selectivity of Anti‐Varicella‐Zoster Virus Nucleoside Analogues

Y. Yoshimura, H. Machida, S. Sakata, 1995, Microbiology and immunology.

5′-O-Alkyl and Acyl Prodrugs of 1-β-D-Arabinofuranosyl-E-5-(2-Bromovinyl)Uracil

H. Machida, Y. Watanabe, S. Sakata, 1994 .

Structure-activity relationship of the affinity of 5-substituted uracil nucleoside analogues for varicella-zoster virus thymidine kinase and their activity against varicella-zoster virus.

T. Suzutani, T. Yamaguchi, H. Machida, 1997, Antiviral research.

A practical synthesis of 4'-thioribonucleosides

K. Asami, K. Haraguchi, Hiromichi Tanaka, 2006 .

In vitro and in vivo anti-herpes viral activities and biological properties of CV-araU.

H. Machida, Y. Watanabe, S. Sakata, 1994, Antiviral research.